Tavalisse

Active Ingredient(s): Fostamatinib
FDA Approved: * April 17, 2018
Pharm Company: * RIGEL PHARMS INC
Category: Immune System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tavalisse Overview

Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug is administered orally as a disodium salt, and is a prodrug of the active compound tamatinib (R-406),[1] which is an inhibitor of the enzyme spleen tyrosine kinase (Syk),[2] hence it is an syk inhibitor. Syk is a protein tyrosine kinase associated with various inflammatory cells, including macrophages, which are presumed to be the cells responsible...

Read more Tavalisse Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fostamatinib

Recent Tavalisse Forums: RSS Feed

Tavalisse for low platelet count / chronic immune thrombocytopenia

A new drug by the name of Tavalisse (fostamatinib disodium hexahydrate) is reportedly being investigated for use in treating adults with a low platelet count due to chronic immune thrombocytopenia (ITP) when other prior treatment options have fallen short. Chronic immune thrombocytopenia is described as an autoimmune bleeding disorder. In patients with ITP, the blood doesn't clot as it should because of a low platelet count. According to clinical trials, more patients who were treated with Tavalisse achieved pre-determined platelet counts, in comparison to patients who received a placebo. FDA APPROVAL DATE: April 17th, 2018 MANUFACTURER: Rigel Pharmaceuticals, Inc. More specific details pertaining to this drug can be viewed at: fda.gov/Drugs/InformationOnDrugs/ucm605411.htm I hope t...

Updated

Possible Dosages for this and Related Drugs:

Fostamatinib
  • Tablet: 100mg, 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tavalisse: (2 results)

Sorted by National Drug Code
  • 71332-001 Tavalisse 100 mg Oral Tablet by Rigel Pharmaceuticals, Inc.
  • 71332-002 Tavalisse 150 mg Oral Tablet by Rigel Pharmaceuticals, Inc.

Other drugs which contain Fostamatinib or a similar ingredient: (1 result)


Related Tavalisse Topics:

Tavalisse for low platelet count / chronic immune thrombocytopenia
A new drug by the name of Tavalisse (fostamatinib disodium hexahydrate) is reportedly being investigated for use in trea...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 18 August 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.